Dr. Stefan Walzer
MAP - Market Access Podcast
Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market...
Be sure to visit the podcast's website and support the creator: marketaccess-pricingstrategy.de
Author
Dr. Stefan Walzer
Category
Podcast website
Latest episode
Nov 15, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
What are the main obstacles in oncology market access, Ed Schoonveld? (Repost) 01.10.2024 38:30
This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023. Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design is important – not only that p...
Is there a place for Real World Evidence in HTA, Dr. Karen Facey? (Repost) 15.09.2024 33:29
This is a repost of a popular MAP, Market Access Podcast, from January 2023. A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also strong advocates of real-world evidence as a complementary way...
How should market access and medical affairs work together, Dr. Mike Rosenblatt? (Repost) 01.09.2024 30:51
In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some core questions: - What are the differences between Clinical De...
Summer Special - Webinar: How AI can revolutionize dossier writing, with special guest Aleksey Zavgorodniy 15.08.2024 34:49
Tune in to the latest episode of MAP, the Market Access Podcast, hosted by Dr Stefan Walzer. In this summer special you will hear some profound insights from the recent MArS Webinar about the new platform DO-Bo - the first and only AI bot for creating reimbursement dossiers globally. Alongside Dr. Stefan Walzer you will also hear from Aleksey Zavgorodniy from Ukraine as they dive deep in...
What are the latest trends in Turkish Healthcare Market Access, Oznur Seyhun? 01.08.2024 34:26
Join us on the latest episode of MAP - the Market Access Podcast - hosted by Dr. Stefan Walzer, as we delve into the dynamic world of market access in Turkey. This episode features Oznur Seyhun, from Market Access Today, who brings expertise from over 20 years of experience in pharmaceutical chemistry, economics, and global management. Explore the latest trends in healthcare market acces...
How will AI shape the future of Market Access and Systematic Reviews, Jeffrey Johnson and Kevin Kallmes? 15.07.2024 34:09
Unlock the Future of Market Access with AI and Systematic Literature Reviews! Join Dr. Stefan Walzer in the latest episode of the Market Access Podcast as he delves into the transformative power of AI in systematic literature searches. Featuring Jeffrey Johnson and Kevin Kallmes from Nested Knowledge, this episode explores how their innovative platform revolutionizes literature reviews, making the...
How can Virtual Reality become a game-changer in Healthcare Training, Rodrigo Silva? 01.07.2024 35:54
Tune in to the new episode of the Market Access Podcast (MAP), where Dr. Stefan Walzer, a pioneer in Market Access 4.0, explores groundbreaking solutions and innovative technologies shaping the future of healthcare reimbursement. Discover how AI-based platforms like Q-Bo and Wafle are revolutionizing health care trainings with all stakeholders. Special guest Rodrigo Silva shares his insights on th...
How Can AI Unlock the Potential of Market Access, Sandip Shah? 15.06.2024 38:36
In the latest episode of MAP - the Market Access Podcast, Dr. Stefan Walzer discusses the transformative power of AI with industry veteran Sandip Shah. With over three decades in healthcare, Sandip shares his journey from sales rep to running Market Access Solutions, emphasizing on how AI is reshaping the landscape. Discover how AI is revolutionizing market research, streamlining dossier pre...
What Does the Future Hold for AI in Healthcare, Aleksey Zavgorodniy? 01.06.2024 34:28
What will the future of AI in healthcare look like? Join us in the latest episode of MAP, the Market Access Podcast, featuring Alexey Zavgorodniy from Unicsoft, and explore the transformative world of artificial intelligence. With extensive experience in AI and large language models, Alexey shares invaluable insights into how AI is reshaping healthcare, pharmaceuticals, and beyond....
How to Decode Market Access in Canada: Are There Essential Tips for Success, Tara Cowling and Jody Filkowski? 15.05.2024 44:38
In the newest episode of MAP - the Market Access podcast, experts Tara Cowling and Jody Filkowski unpacks the complexities and nuances of Canada's market access for pharmaceuticals and medical devices. From regulatory hurdles to intricate reimbursement pathways, they shed light on what it takes to successfully navigate this diverse and challenging landscape. Whether you're dealing with drugs or me...
How has virtual become reality in market access, Glib Kutepov? 01.05.2024 31:08
What role will AI & VR transformations play in the future? Tune in to this fascinating episode of the Market Access Podcast to hear as our special guest, Glib Kutepov, CEO and founder of Modulate, shares his expertise. Glib uncovers the potential of generative AI and neural networks in revolutionizing market access strategies and highlights the challenges and solutions around data privac...
What Makes Italy's Healthcare System So Complex, Giacomo Matteo Bruno? 16.04.2024 31:28
Tune into a brand new episode of the Market Access Podcast to listen to an intriguing conversation about the Italian healthcare system with Giacomo Matteo Bruno and Dr Stefan Walzer. Together they explore the balance between innovation, sustainability, and patient access in the heart of Europe. Discover the evolution, challenges, and future of healthcare in Italy, from the foundational principles...
Is Healthcare Just a Business in the US, Aymeric Chaupin? 01.04.2024 33:06
In this captivating episode of MAP, the Market Access Podcast, we welcome Aymeric Chaupin, a seasoned expert in pricing and market access. Aymeric's unique perspective, shaped by his deep understanding of both the American and European healthcare systems, sheds light on the complexities of healthcare reimbursement pathways in the US and their impact on the delivery of health services. Join us as A...
A Flourishing Career in Pharmaceutical Market Access: Which Skills Are Essential, Dipti Tankala? 15.03.2024 32:02
Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights on making impactful career transitions. Market Access veteran Dr. Stefan Walzer and Dipti Tankala also talk about the significance of network...
Mastering US Market Access: What are proven Strategies for Success, Paul-Lukas Hoffschmidt? 01.03.2024 33:08
In this essential episode of the Market Access Podcast, we're diving deep into the critical aspects of commercializing healthcare innovations in the US market. Whether you're in medtech, pharma, biotech, or health tech, understanding the US healthcare landscape is key to your product's success. Join us as Dr. Stefan Walzer and Paul-Lukas Hoffschmidt, CEO of Alpha Sophia ( www.alphasophia.com ), sh...
Beyond the CE Mark: How can we achieve Medtech Reimbursement in France, Dr. Benoit Salaun? 15.02.2024 34:25
Join us for a fascinating dive into the complexities of French market access with our latest episode of the Map Podcast. Dr. Stefan Walzer, health economist and founder of Mars Market Access & Pricing Strategy, engages with Dr. Benoit Salaun, a seasoned expert in French healthcare reimbursement. They unravel: The nuances of the French healthcare system The essentials of medical device reimburs...
Remo Christen – Early paid access in Switzerland – Switzerland, wonderland? (Repost) 01.02.2024 34:11
In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement including the famous article 71, which allows an early paid access. Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate. In this episo...
How can we overcome the complexity of market access for medical devices in Spain, Sergio Gil? 15.01.2024 33:15
Are you intrigued by the pulsing heart of Spain’s healthcare sector, or are you considering navigating the vibrant market of medical devices in Spain? Dive into our latest Market Access podcast episode where we unravel the complexities and dynamism of Spain’s medical landscape. 🇪🇸 Join us as Sergio Gil , a seasoned veteran with over three decades in the medical device industry, shares his invaluab...
What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian? (Repost) 15.12.2023 33:41
We are looking at Israel a lot recently, but did you know how innovative this rather small country is in terms of healthcare? Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the same time, Israel has a higher life expectancy and lower infant mortality. So, better results for less money?! How does Israel do this? Dr. Stefan Walze...
The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff 01.12.2023 33:53
We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff. Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of healthcare reimbursement, a journey from simpler times to today's intricate landscape involving m...
Navigating the Healthcare Startup Galaxy - key insights with Dr. Thomas Kerscher and Mark Anken. 15.11.2023 34:06
🎧 Excited to share our CEO, Dr. Stefan Walzer's newest Market Access podcast episode that's nothing short of a masterclass for healthcare startups venturing into the European market! In this engaging episode, Dr. Walzer sits down with Dr. Thomas Kerscher and Mark Anken, both titans in the healthcare and pharmaceutical sectors with over two decades of experience. Currently at the helm of advantage...
How to navigate complexities, Aurelie Moser: Market Access in Digital Health vs. Drugs? 01.11.2023 32:00
🎙️ Exciting Podcast Episode Is Here! 🎙️ In this episode of our podcast series, I'm excited to share that Stefan Walzer, a seasoned reimbursement expert, hosts the incredibly talented Amelie Moser, a business consultant with two decades of unparalleled expertise in market access! 🎯 What's Happening? Immerse yourself in the fascinating world of digital health and see how it sharply contrasts with t...
AMNOG 2.0 - significant changes for the industry since January 2023, correct - Dr. Flume? 15.10.2023 31:00
Join us in the latest episode where pharmacist and head of a regional physicians association, Matthias Flume, engages in a thought-provoking discussion with host Stefan Walzer, exploring the intricate tapestry of reforms enveloped within the AMNOG (Arzneimittelmarktneuordnungsgesetz) 2.0, especially scrutinizing those unveiled in 2023! 🚀 Dive Deep into the Core of Pharmaceutical Reforms! Matthias...
Inside the Swiss decision-makers - how does the system for drugs really work, Dr. Heiner Sandmeier? 01.10.2023 36:26
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi Switzerland is seen as a small but still attractive market for pharmaceuticals, even though that the Swiss decision-makers are considered as tough and sometimes even difficult. A core issue might especially be, that the assessment and negotiations primarily happen intransparently „behind the doors“. ...
How should market access and medical affairs work together, Dr. Mike Rosenblatt? 15.09.2023 30:49
Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi We are living in an age of massive medical innovation including a lot of new modalities especially in the area of ATMPs, but also beyond. Within this area, but obviously also beyond, there are core questions in the area of tensions such as the followings: - What are the differences between Clinical Develop...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.